Filing Details
- Accession Number:
- 0001209191-22-023904
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-08 19:24:54
- Reporting Period:
- 2022-04-06
- Accepted Time:
- 2022-04-08 19:24:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1496323 | Igm Biosciences Inc. | IGMS | Pharmaceutical Preparations (2834) | 770349194 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1787362 | Bruce Keyt | C/O Igm Biosciences, Inc. 325 E. Middlefield Road Mountain View CA 94043 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-04-06 | 2,500 | $0.93 | 42,515 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-04-06 | 2,500 | $25.00 | 40,015 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2022-04-06 | 2,500 | $0.00 | 2,500 | $0.93 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
133,756 | 2023-01-12 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,013 | Indirect | See footnote |
Footnotes
- The option exercise and sale were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
- The shares are held directly by the reporting person's spouse.
- The shares subject to the option are vested and exercisable as of the date hereof.